Quoin Pharma regains Nasdaq minimum bid price compliance; delisting risk removed

Quoin Pharmaceuticals, Ltd.

Received Nasdaq Compliance Notice on April 29, 2025 confirming minimum bid price compliance.
Closing bid price of ADSs was $1.00 or above for 10 consecutive trading days (April 9-28).
Nasdaq closed the matter; no further action required from company.

item 8.01

Quoin Pharmaceuticals, Ltd. filing history →

Source: SEC EDGAR

accession 0001104659-25-042661

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.